chr16-1229314-C-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate

The NM_024164.6(TPSB2):ā€‹c.376G>Cā€‹(p.Glu126Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…).

Frequency

Genomes: š‘“ 0.0023 ( 0 hom., cov: 3)
Exomes š‘“: 0.00074 ( 23 hom. )
Failed GnomAD Quality Control

Consequence

TPSB2
NM_024164.6 missense

Scores

1
12

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -2.00
Variant links:
Genes affected
TPSB2 (HGNC:14120): (tryptase beta 2) Tryptases comprise a family of trypsin-like serine proteases, the peptidase family S1. Tryptases are enzymatically active only as heparin-stabilized tetramers, and they are resistant to all known endogenous proteinase inhibitors. Several tryptase genes are clustered on chromosome 16p13.3. These genes are characterized by several distinct features. They have a highly conserved 3' UTR and contain tandem repeat sequences at the 5' flank and 3' UTR which are thought to play a role in regulation of the mRNA stability. These genes have an intron immediately upstream of the initiator Met codon, which separates the site of transcription initiation from protein coding sequence. This feature is characteristic of tryptases but is unusual in other genes. The alleles of this gene exhibit an unusual amount of sequence variation, such that the alleles were once thought to represent two separate genes, beta II and beta III. Beta tryptases appear to be the main isoenzymes expressed in mast cells, whereas in basophils, alpha-tryptases predominate. Tryptases have been implicated as mediators in the pathogenesis of asthma and other allergic and inflammatory disorders. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018770158).
BP6
Variant 16-1229314-C-G is Benign according to our data. Variant chr16-1229314-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 2346351.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TPSB2NM_024164.6 linkuse as main transcriptc.376G>C p.Glu126Gln missense_variant 4/6 ENST00000606293.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TPSB2ENST00000606293.5 linkuse as main transcriptc.376G>C p.Glu126Gln missense_variant 4/61 NM_024164.6 P2

Frequencies

GnomAD3 genomes
AF:
0.00238
AC:
39
AN:
16414
Hom.:
0
Cov.:
3
show subpopulations
Gnomad AFR
AF:
0.0157
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00376
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00490
GnomAD3 exomes
AF:
0.00104
AC:
61
AN:
58464
Hom.:
1
AF XY:
0.000850
AC XY:
26
AN XY:
30592
show subpopulations
Gnomad AFR exome
AF:
0.0132
Gnomad AMR exome
AF:
0.000588
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000547
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000741
AC:
369
AN:
497862
Hom.:
23
Cov.:
6
AF XY:
0.000632
AC XY:
161
AN XY:
254740
show subpopulations
Gnomad4 AFR exome
AF:
0.0230
Gnomad4 AMR exome
AF:
0.00192
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000831
Gnomad4 OTH exome
AF:
0.00194
GnomAD4 genome
AF:
0.00225
AC:
37
AN:
16420
Hom.:
0
Cov.:
3
AF XY:
0.00244
AC XY:
17
AN XY:
6974
show subpopulations
Gnomad4 AFR
AF:
0.0145
Gnomad4 AMR
AF:
0.00375
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00485
Alfa
AF:
0.00438
Hom.:
2
ExAC
AF:
0.0000616
AC:
2

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsJul 27, 2021This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
13
DANN
Benign
0.71
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.81
T;T
M_CAP
Uncertain
0.088
D
MetaRNN
Benign
0.019
T;T
MetaSVM
Benign
-0.69
T
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.29
T
Sift4G
Benign
0.84
T;T
Vest4
0.19
MutPred
0.55
Loss of disorder (P = 0.1231);.;
MVP
0.29
ClinPred
0.026
T
GERP RS
-1.2
gMVP
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs770859378; hg19: chr16-1279315; API